Legal pathways and case law on photobiomodulation therapy for oral mucositis in cancer care: a retrospective cross-sectional study
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology · 2025
DOI: 10.1016/j.oooo.2025.05.006 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2025. Verfasst von Danielle Martins Startari und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas, Piracicaba, SP, Brazil. Hauptthemen laut MEDLINE: Stomatitis, Low-Level Light Therapy, Neoplasms, Health Services Accessibility. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Coordination of Higher Education Personnel Improvement, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.
Themen: Onkologische Pflege
Abstract (Originalsprache)
OBJECTIVE: Oral mucositis (OM) is a common and debilitating complication of cancer therapy that can be prevented with photobiomodulation therapy (PBMT), a light-based intervention recommended by international guidelines. This study aimed to identify the legal pathways to patient access to PBMT for OM in Brazilian cancer care. STUDY DESIGN: This retrospective cross-sectional study assessed electronic databases of the Courts of Justice from all Brazilian states, the Superior Court of Justice, and the Federal Supreme Court, yielding 180 court rulings for "mucositis". RESULTS: A total of 50 court rulings, adjudicated between 2005 and 2024, met the eligibility criteria. Of these, 41 (82%) were fully granted and 9 (18%) partially granted, typically denying compensation for moral damages. In 47 cases (94%), the rulings were directed to health insurance providers, while 3 (6%) involved the public healthcare system. The mean time from filing to interim relief was 13.3 days (SD = 28.3; range: 1-115). Chemotherapy was the most common cancer treatment, followed by radiotherapy and hematopoietic stem cell transplantation. CONCLUSIONS: This novel study reveals a consistent legal framework supporting access to PBMT for OM in Brazil, reflecting a progressive judicial stance with potential implications for health policy and supportive cancer care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas, Piracicaba, SP, Brazil.
- Private Practice, São Paulo, SP, Brazil.
- Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas, Piracicaba, SP, Brazil. Electronic address: alan@unicamp.br.
Förderung
- Coordination of Higher Education Personnel Improvement
- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
Zitieren
APA
Startari, D. M., Esteves-Pereira, T. C., Wolkart, E. N., Pires, M., Lopes, M. A., & Santos-Silva, A. R. (2025). Legal pathways and case law on photobiomodulation therapy for oral mucositis in cancer care: a retrospective cross-sectional study. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. https://doi.org/10.1016/j.oooo.2025.05.006
Vancouver
Startari DM, Esteves-Pereira TC, Wolkart EN, Pires M, Lopes MA, Santos-Silva AR. Legal pathways and case law on photobiomodulation therapy for oral mucositis in cancer care: a retrospective cross-sectional study. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2025. doi:10.1016/j.oooo.2025.05.006
BibTeX
@article{Startari2025,
author = {Startari, Danielle Martins and Esteves-Pereira, Thaís Cristina and Wolkart, Erik Navarro and Pires, Marcela and Lopes, Marcio Ajudarte and Santos-Silva, Alan Roger},
title = {Legal pathways and case law on photobiomodulation therapy for oral mucositis in cancer care: a retrospective cross-sectional study},
journal = {Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology},
year = {2025},
doi = {10.1016/j.oooo.2025.05.006}
}
EUVIMED